3-arylisoquinolinamine derivative
3-arylisoquinolinamine derivative is a 3-arylisoquinolinamine derivative with antitumor activity.
Product Specifications
CAS Number
[1029008-71-6]
UNSPSC
12352005
Target
Drug Derivative
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/3-arylisoquinolinamine_derivative.html
Purity
99.42
Solubility
DMSO : ≥ 50 mg/mL
Smiles
NC1=NC(C2=CC=CC(OC)=C2)=CC(C=C3)=C1C=C3N(C)C
Molecular Formula
C18H19N3O
Molecular Weight
293.36
References & Citations
[1]Yang SH, et al. Synthesis, in vitro and in vivo evaluation of 3-arylisoquinolinamines as potent antitumor agents. Bioorg Med Chem Lett. 2010 Sep 1;20 (17) :5277-81.|[2]Young Bok Lee, et al. 5, 6, or 7-substituted-s- (hetero) arylisoquinolinamine derivatives as antitumor agents. WO 2008063548 A2.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![2-chloro-N-[3- (4-ethoxybenzoyl) -6-methyl-4,5,6,7-tetrahydro-1-benzothien-2-yl]acetamide](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
sc-342254 250 mg
2-chloro-N-[3- (4-ethoxybenzoyl) -6-methyl-4,5,6,7-tetrahydro-1-benzothien-2-yl]acetamide
Ask
View Details TA801895AM 100 µL
VILIP1 (VSNL1) Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI2E6G5]
Ask
View Details